Czirr James C 的 Form 4 申報
Galectin Therapeutics IncGALT,2025/12/18 申報
- 申報編號
- 0001493152-25-028303
- 申報時間
- 2025/12/18 10:34 ET
- 交易日
- 2025/11/24-12/16
- 申報延遲
- 24 天遲報
- 10b5-1 計畫
- 沒有勾選
這份申報列了 2 筆非衍生性交易。公開市場賣出合計 $20.4 萬。交易後 24 天才申報,超過 2 個營業日的期限。
申報人
一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Czirr James CCIK 0001260641 | 持股 10% 以上大股東 |
| 10X Fund, L.P.CIK 0001453356 | 持股 10% 以上大股東 |
| 10X Capital Management, LLCCIK 0001457247 | 持股 10% 以上大股東 |
非衍生性證券(表 I)
普通股等股票的取得與處分,每一列是申報上的一筆。
附註與備註
本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。
- F1
Shares were distributed in an in-kind distribution to a withdrawing limited partner of 10X Fund, LP of his/her/its pro rata share of shares held by 10X Fund, LP, which did not receive any consideration for the transfer. The distribution is exempt from Section 16(b) because it does not constitute a sale of a security under applicable law.
表 I 有 1 筆交易的價格引用這則附註。
- F3
The shares were sold in multiple transactions at prices ranging from $6.64 to $6.69. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
表 I 有 1 筆交易的價格引用這則附註。